Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma

Clinical trial NCT07300683 · RECRUITING

Trial details

NCT number: NCT07300683
Sponsor: University College, London
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T Cell Acute Lymphoblastic Leukemia T Cell Lymphoblastic Lymphoma

Start date: 2025-11-11
Primary completion: 2027-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.